Supporter and Exhibitor Opportunities
NCCN Guidelines and Compendium Updated
Flash Update Sent June 20, 2012
NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Lung Cancer Screening. These NCCN Guidelines® are currently available as Version 1.2013.
- New footnote added describing the candidates for lung cancer screening: "Lung cancer screening is appropriate to consider for those high-risk patients who are potential candidates for definitive treatment."
- For individuals who are candidates for screening, the interval has been revised: "Annual low-dose computed tomography (LDCT) for 2 years (category 1), and consider annual LDCT until patient no longer eligible for definitive treatment"
- New footnote added to define criteria for suspicion of malignancy on PET-CT: "Criteria for suspicion of malignancy: hypermetabolism higher than the background of surrounding lung parenchyma, regardless of absolute standardized uptake value (SUV)."
For the complete updated version of these and all NCCN Guidelines, visit NCCN.org.